Treoall 5 gm Injection 1's

Treoall 5 gm Injection 1's belongs to the group of anti-cancer medicines called alkylating agents indicated in the treatment of advanced ovarian cancer after at least one prior standard therapy. Ovarian cancer occurs when abnormal cells grow and multiply in the ovaries and fallopian tubes.
 
Treoall 5 gm Injection 1's contains Treosulfan, which works by inhibiting tumour growth. It prevents the cancer cells from multiplying. This helps reduce the number of cancer cells and helps treat ovarian cancer.
 
In some cases, Treoall 5 gm Injection 1's may cause side effects such as nausea, vomiting, mild hair loss, and bronze discolouration of the skin. Most of these side effects may not require medical attention and resolve over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
 
Consult the doctor if you are pregnant, breastfeeding, or think you may be pregnant or are planning for pregnancy. Treoall 5 gm Injection 1's is not recommended for children. Inform the doctor about your health condition and medications to rule out any side effects/interactions.

Treoall 5 gm Injection 1's is used to treat Ovarian cancer.

• Hematopoietic Stem Cell Transplant (HSCT) Conditioning: Used as part of pre-transplant chemotherapy to prepare the bone marrow for transplantation.
• Often combined with fludarabine.
• Indicated for malignant diseases (like acute myeloid leukemia, myelodysplastic syndromes) and non-malignant diseases (like bone marrow failure syndromes, immunodeficiencies).
• Alternative to Busulfan
• Considered less toxic than busulfan in some cases.
• Preferred for pediatric and adult patients who cannot tolerate high toxicity regimens.
• Treatment of Ovarian Cancer (off-label in some regions)
• Previously used in recurrent ovarian cancer as palliative chemotherapy.
• Now mainly replaced by newer drugs, but still an option in some cases.

Treoall 5 gm Injection 1's belongs to the group of anti-cancer medicines called bifunctional alkylating agents indicated in the treatment of advanced ovarian cancer after at least one prior standard therapy. Treoall 5 gm Injection 1's contains Treosulfan, which works by inhibiting tumour growth. Thereby, it helps treat ovarian cancer.

Treoall 5 gm Injection 1's will be administered by a healthcare professional; do not self-administer.

Do not use Treoall 5 gm Injection 1's if you are allergic to any of its components, if you have severe bone marrow depression, or if you are breastfeeding. Inform the doctor if you have lung inflammation, kidney problems or if you are undergoing any vaccination. Be cautious as Treoall 5 gm Injection 1's may increase the risk of infections and blood cancers after long-term treatment. Consult the doctor if you are pregnant, think you are pregnant or planning for pregnancy. Let the doctor know if you are taking any other medicines, including supplements and herbal products.

• Your doctor may advise regular blood tests to check for blood cell count.

• Women of childbearing potential must use reliable contraception during treatment with Treoall 5 gm Injection 1's and for at least six months after the treatment.

• Drink more fluids than usual for up to 24 hours after your treatment.